-
Canadians have access to fewer new medicines than most OECD countries: Rx&D
OTTAWA | Compared to 32 other developed countries, Canada's public drug plans perform poorly in providing access to new medicines and vaccines, according to the 2011-2012 International Report on Access to Medicines from Canada's Research-Based Pharmaceutical Companies (Rx&D).